Related Articles
Acquired/intratumoral mutation of KRAS during metastatic progression of colorectal carcinogenesis
Genetic analysis and clinical investigation of a pedigree with multiple endocrine neoplasia type 2A: A case report
KRAS mutations in patients with colorectal cancer in Libya
Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules